UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Antibody-drug conjugates in solid tumors: a look into novel targets

Journal of hematology and oncology, 2021-01, Vol.14 (1), p.20-20, Article 20

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

CA: a cancer journal for clinicians, 2016-07, Vol.66 (4), p.309-325

2016

Link zum Volltext

Verfügbarkeit prüfen

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

NPJ breast cancer, 2020-10, Vol.6 (1), p.54-54, Article 54

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Pathways: Human Leukocyte Antigen G (HLA-G)

Clinical cancer research, 2013-10, Vol.19 (20), p.5564-5571

2013

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Genetics: Diagnostics and Treatment

Genes, 2022-09, Vol.13 (9), p.1593

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art

Breast (Edinburgh), 2017-10, Vol.35, p.142-150

2017

Link zum Volltext

Verfügbarkeit prüfen

Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling

Clinical cancer research, 2012-03, Vol.18 (5), p.1341-1351

2012

Link zum Volltext

Verfügbarkeit prüfen

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective

ESMO open, 2020-03, Vol.5 (2), p.e000759, Article e000759

2020

Link zum Volltext

Verfügbarkeit prüfen

Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis

Journal of clinical oncology, 2012-06, Vol.30 (16), p.1996-2004

2012

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Frontiers in oncology, 2021-03, Vol.11, p.644737-644737

2021

Link zum Volltext

Verfügbarkeit prüfen

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

Cancers, 2020-03, Vol.12 (4), p.819

2020

Link zum Volltext

Verfügbarkeit prüfen

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer

Frontiers in molecular biosciences, 2022-03, Vol.9, p.834651-834651

2022

Link zum Volltext

Verfügbarkeit prüfen

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

Pharmaceuticals (Basel, Switzerland), 2014-09, Vol.7 (9), p.943-953

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in Gastrointestinal Cancers

BioMed research international, 2017-01, Vol.2017, p.4346576-17

2017

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Cells (Basel, Switzerland), 2021-06, Vol.10 (6), p.1377

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study

Frontiers in oncology, 2020-10, Vol.10, p.556718-556718

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers

Frontiers in molecular biosciences, 2023-01, Vol.9, p.1117323-1117323

2023

Link zum Volltext

Verfügbarkeit prüfen

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

ESMO open, 2020-05, Vol.5 (Suppl 3), p.e000793-e000793, Article e000793

2020

Link zum Volltext

Verfügbarkeit prüfen

Future potential targets of antibody-drug conjugates in breast cancer

Breast (Edinburgh), 2023-06, Vol.69, p.312-322

2023

Link zum Volltext

Verfügbarkeit prüfen

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

Journal of clinical oncology, 2008-01, Vol.26 (1), p.44-53

2008

Link zum Volltext

Verfügbarkeit prüfen

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

Breast cancer research : BCR, 2019-11, Vol.21 (1), p.123-123, Article 123

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander"

Toxins, 2014-03, Vol.6 (3), p.914-933

2014

Link zum Volltext

Verfügbarkeit prüfen

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Genes, 2020-06, Vol.11 (7), p.719

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials

Frontiers in oncology, 2022-01, Vol.11, p.829875-829875

2022

Link zum Volltext

Verfügbarkeit prüfen

HER2-positive circulating tumor cells in breast cancer

PloS one, 2011-01, Vol.6 (1), p.e15624-e15624

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Antibody-drug conjugates in solid tumors: a look into novel targets

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Molecular Pathways: Human Leukocyte Antigen G (HLA-G)

Breast Cancer Genetics: Diagnostics and Treatment

Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art

Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective

Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis

PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

Immunotherapy in Gastrointestinal Cancers

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

Future potential targets of antibody-drug conjugates in breast cancer

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander"

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials

HER2-positive circulating tumor cells in breast cancer

Suchergebnisse filtern